Cargando…
Circulating tumor DNA in lung cancer: real-time monitoring of disease evolution and treatment response
Lung cancer is one of the leading causes of all cancer-related deaths. Circulating tumor DNA (ctDNA) is released from apoptotic and necrotic tumor cells. Several sensitive techniques have been invented and adapted to quantify ctDNA genomic alterations. Applications of ctDNA in lung cancer include ea...
Autores principales: | Li, Rui-Yu, Liang, Zhi-Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575184/ https://www.ncbi.nlm.nih.gov/pubmed/32960843 http://dx.doi.org/10.1097/CM9.0000000000001097 |
Ejemplares similares
-
Real-Time Molecular Monitoring in Acute Myeloid Leukemia With Circulating Tumor DNA
por: Thakral, Deepshi, et al.
Publicado: (2020) -
Circulating tumor DNA for personalized lung cancer monitoring
por: Fiala, Clare, et al.
Publicado: (2017) -
Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade
por: Lipson, Evan J, et al.
Publicado: (2014) -
BC-Monitor: Towards a Routinely Accessible Circulating Tumor DNA-Based Tool for Real-Time Monitoring Breast Cancer Progression and Treatment Effectiveness
por: Priskin, Katalin, et al.
Publicado: (2021) -
Real-world circulating tumor DNA analysis depicts resistance mechanism and clonal evolution in ALK inhibitor-treated lung adenocarcinoma patients
por: Hua, G., et al.
Publicado: (2022)